DE3203775A1 - Fibrinogenzubereitung, verfahen zu ihrer herstellungund ihre verwendung - Google Patents

Fibrinogenzubereitung, verfahen zu ihrer herstellungund ihre verwendung

Info

Publication number
DE3203775A1
DE3203775A1 DE19823203775 DE3203775A DE3203775A1 DE 3203775 A1 DE3203775 A1 DE 3203775A1 DE 19823203775 DE19823203775 DE 19823203775 DE 3203775 A DE3203775 A DE 3203775A DE 3203775 A1 DE3203775 A1 DE 3203775A1
Authority
DE
Germany
Prior art keywords
fibrinogen
preparation
percent
preparation according
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19823203775
Other languages
German (de)
English (en)
Inventor
Wolfgang 3554 Gladenbach Burk
Peter Dipl.-Chem. Dr. 3551 Lahntal Fuhge
Norbert Prof. Dr. 3550 Marburg Heimburger
Hans-Arnold 3552 Wetter Stöhr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6154769&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3203775(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Behringwerke AG filed Critical Behringwerke AG
Priority to DE19823203775 priority Critical patent/DE3203775A1/de
Priority to EP83100869A priority patent/EP0085923B2/de
Priority to AT83100869T priority patent/ATE22806T1/de
Priority to DE8383100869T priority patent/DE3366841D1/de
Priority to NZ203164A priority patent/NZ203164A/en
Priority to AR292015A priority patent/AR231233A1/es
Priority to GR70394A priority patent/GR77184B/el
Priority to FI830361A priority patent/FI77985C/fi
Priority to IL67823A priority patent/IL67823A/xx
Priority to ES519469A priority patent/ES8403321A1/es
Priority to PT76193A priority patent/PT76193B/pt
Priority to DK044483A priority patent/DK158282C/da
Priority to JP58015556A priority patent/JPS58135817A/ja
Priority to AU11105/83A priority patent/AU556068B2/en
Priority to IE207/83A priority patent/IE54547B1/en
Priority to CA000420880A priority patent/CA1186995A/en
Priority to NO830371A priority patent/NO155177B/no
Priority to ZA83726A priority patent/ZA83726B/xx
Publication of DE3203775A1 publication Critical patent/DE3203775A1/de
Priority to US06/639,617 priority patent/US4650678A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE19823203775 1982-02-04 1982-02-04 Fibrinogenzubereitung, verfahen zu ihrer herstellungund ihre verwendung Withdrawn DE3203775A1 (de)

Priority Applications (19)

Application Number Priority Date Filing Date Title
DE19823203775 DE3203775A1 (de) 1982-02-04 1982-02-04 Fibrinogenzubereitung, verfahen zu ihrer herstellungund ihre verwendung
EP83100869A EP0085923B2 (de) 1982-02-04 1983-01-31 Fibrinogenzubereitung, Verfahren zu ihrer Herstellung und ihre Verwendung
AT83100869T ATE22806T1 (de) 1982-02-04 1983-01-31 Fibrinogenzubereitung, verfahren zu ihrer herstellung und ihre verwendung.
DE8383100869T DE3366841D1 (en) 1982-02-04 1983-01-31 Fibrinogen preparation, process for its manufacture and use thereof
ES519469A ES8403321A1 (es) 1982-02-04 1983-02-02 Procedimiento para la produccion de un preparado solido de fibrinogeno.
IL67823A IL67823A (en) 1982-02-04 1983-02-02 Fibrinogen formulation and a process for its preparation
AR292015A AR231233A1 (es) 1982-02-04 1983-02-02 Procedimiento para la produccion de fibrinogeno
GR70394A GR77184B (cg-RX-API-DMAC7.html) 1982-02-04 1983-02-02
FI830361A FI77985C (fi) 1982-02-04 1983-02-02 Foerfarande foer framstaellning av en fibrinogenprodukt.
NZ203164A NZ203164A (en) 1982-02-04 1983-02-02 Solid fibrinogen formulation
ZA83726A ZA83726B (en) 1982-02-04 1983-02-03 Fibrinogen formulations,a process for its preparation and its use
AU11105/83A AU556068B2 (en) 1982-02-04 1983-02-03 Fibrinogen formulation into tissue adhesive and intravenous concentrate
DK044483A DK158282C (da) 1982-02-04 1983-02-03 Fremgangsmaade til fremstilling af et fast fibrinogenpraeparat
JP58015556A JPS58135817A (ja) 1982-02-04 1983-02-03 フイブリノ−ゲン製剤およびその製法
PT76193A PT76193B (de) 1982-02-04 1983-02-03 Fibrinogenzubereitung verfahren zu ihrer herstellung und ihre verwendung
IE207/83A IE54547B1 (en) 1982-02-04 1983-02-03 Fibrinogen formulation, a process for its preparation and its use
CA000420880A CA1186995A (en) 1982-02-04 1983-02-03 Fibrinogen formulation, a process for its preparation and its use
NO830371A NO155177B (no) 1982-02-04 1983-02-03 Fremgangsmaate til fremstilling av et fast fibrinogenpreparat.
US06/639,617 US4650678A (en) 1982-02-04 1984-08-10 Readily dissolvable lyophilized fibrinogen formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823203775 DE3203775A1 (de) 1982-02-04 1982-02-04 Fibrinogenzubereitung, verfahen zu ihrer herstellungund ihre verwendung

Publications (1)

Publication Number Publication Date
DE3203775A1 true DE3203775A1 (de) 1983-08-11

Family

ID=6154769

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19823203775 Withdrawn DE3203775A1 (de) 1982-02-04 1982-02-04 Fibrinogenzubereitung, verfahen zu ihrer herstellungund ihre verwendung
DE8383100869T Expired DE3366841D1 (en) 1982-02-04 1983-01-31 Fibrinogen preparation, process for its manufacture and use thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE8383100869T Expired DE3366841D1 (en) 1982-02-04 1983-01-31 Fibrinogen preparation, process for its manufacture and use thereof

Country Status (18)

Country Link
US (1) US4650678A (cg-RX-API-DMAC7.html)
EP (1) EP0085923B2 (cg-RX-API-DMAC7.html)
JP (1) JPS58135817A (cg-RX-API-DMAC7.html)
AR (1) AR231233A1 (cg-RX-API-DMAC7.html)
AT (1) ATE22806T1 (cg-RX-API-DMAC7.html)
AU (1) AU556068B2 (cg-RX-API-DMAC7.html)
CA (1) CA1186995A (cg-RX-API-DMAC7.html)
DE (2) DE3203775A1 (cg-RX-API-DMAC7.html)
DK (1) DK158282C (cg-RX-API-DMAC7.html)
ES (1) ES8403321A1 (cg-RX-API-DMAC7.html)
FI (1) FI77985C (cg-RX-API-DMAC7.html)
GR (1) GR77184B (cg-RX-API-DMAC7.html)
IE (1) IE54547B1 (cg-RX-API-DMAC7.html)
IL (1) IL67823A (cg-RX-API-DMAC7.html)
NO (1) NO155177B (cg-RX-API-DMAC7.html)
NZ (1) NZ203164A (cg-RX-API-DMAC7.html)
PT (1) PT76193B (cg-RX-API-DMAC7.html)
ZA (1) ZA83726B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5318782A (en) * 1986-10-03 1994-06-07 Weis Fogh Ulla S Method for preparing tissue repair promoting substances

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0672105B2 (ja) * 1985-10-02 1994-09-14 持田製薬株式会社 血栓溶解剤及びその製法
DE3622642A1 (de) * 1986-07-05 1988-01-14 Behringwerke Ag Einkomponenten-gewebekleber sowie verfahren zu seiner herstellung
US4743632A (en) * 1987-02-25 1988-05-10 Pfizer Hospital Products Group, Inc. Polyetherurethane urea polymers as space filling tissue adhesives
US5449759A (en) * 1987-05-16 1995-09-12 Somatogen, Inc. Hemoglobins with intersubunit desulfide bonds
FR2618784B1 (fr) * 1987-07-30 1990-04-06 Lille Transfusion Sanguine Concentre de proteines coagulables par la thrombine, son procede d'obtention et son utilisation a titre de colle biologique
AT407834B (de) * 1987-10-08 2001-06-25 Aventis Behring Gmbh Einkomponenten-gewebekleber sowie verfahren zu seiner herstellung
DE3734923C1 (de) * 1987-10-15 1989-01-26 Biotest Pharma Gmbh Verfahren zur Herstellung einer sterilen Plasmaproteinloesung,die Fibrinogen und den Gerinnungsfaktor XIII enthaelt
AT397203B (de) * 1988-05-31 1994-02-25 Immuno Ag Gewebeklebstoff
FR2639958B1 (fr) * 1988-12-06 1992-08-21 Lille Transfusion Sanguine Support biologique pour cultures cellulaires constitue de proteines plasmatiques coagulees par la thrombine, son utilisation pour la culture des keratinocytes, leur recuperation et leur transport a des fins d'utilisation therapeutique
US4980165A (en) * 1989-01-27 1990-12-25 Genetics Institute, Inc. Pharmaceutical formulations of plasminogen activator proteins
FR2663226B1 (fr) * 1990-06-15 1994-11-18 Fondation Nale Transfusion San Colle biologique fluide.
IE912528A1 (en) * 1990-07-19 1992-01-29 Scripps Clinic Res Inhabition of mac-1 receptor binding fibrinogen using d30¹homologs
US5644032A (en) * 1990-08-06 1997-07-01 Fibrin Corporation Process for producing fibrinogen concentrates
US5420250A (en) * 1990-08-06 1995-05-30 Fibrin Corporation Phase transfer process for producing native plasma protein concentrates
US6197325B1 (en) * 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6054122A (en) 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
DE4202667C1 (cg-RX-API-DMAC7.html) 1992-01-29 1993-05-13 Behringwerke Ag, 3550 Marburg, De
AU670793B2 (en) * 1992-04-30 1996-08-01 Alpha Therapeutic Corporation Improved solubilization and stabilization of factor VIII complex
US5599790A (en) * 1992-06-11 1997-02-04 The Scripps Research Institute Fibrinogen γ chain polypeptide and compositions thereof
EP0644768B1 (en) * 1992-06-11 2001-11-21 The Scripps Research Institute Methods and compositions for inhibiting endothelial cell and fibrinogen mediated inflammation
US5385606A (en) * 1992-07-06 1995-01-31 Kowanko; Nicholas Adhesive composition and method
CN1091315A (zh) * 1992-10-08 1994-08-31 E·R·斯奎布父子公司 血纤维蛋白封闭剂组合物及其使用方法
WO1994008891A1 (en) * 1992-10-14 1994-04-28 Novozone (N.Z.) Limited Ozone generation apparatus and method
US5330974A (en) * 1993-03-01 1994-07-19 Fibratek, Inc. Therapeutic fibrinogen compositions
ATE273035T1 (de) * 1993-11-03 2004-08-15 Clarion Pharmaceuticals Inc Hämostatisches pflaster
EP0758903A4 (en) * 1994-03-31 1998-11-18 Fibrin Corp CONCENTRATES OF CRYOPRECIPTED, NATURAL FIBRINOGEN
US5585007A (en) * 1994-12-07 1996-12-17 Plasmaseal Corporation Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant
WO1997033633A1 (en) * 1996-03-15 1997-09-18 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Tissue adhesive applied with spray
ATE298582T1 (de) 1996-04-19 2005-07-15 Alpha Therapeutic Corp Verfahren zur inaktivierung von viren und lyophilisierung von blutproteinen
DE19617369A1 (de) * 1996-04-30 1997-11-06 Immuno Ag Lagerstabile Fibrinogen-Präparate
ATE439150T1 (de) 1997-11-17 2009-08-15 Haemacure Corp Ein hyaluronsäurederivat enthaltende fibrinsiegel-oder fibrinklebmasse
AUPP276098A0 (en) * 1998-04-01 1998-04-30 Nokuta Pty Ltd A method for treating gelatine
CN1335757A (zh) * 1998-11-12 2002-02-13 聚合体生物科学公司 可用于快速凝血和止血的止血聚合物
PT1151007E (pt) * 1999-02-12 2006-07-31 Baxter Ag Metodo para produzir uma preparacao com base em fibrinogenio e fibronectina assim como composicoes proteicas obteniveis de acordo com este metodo
ES2156731B1 (es) * 1999-05-31 2002-02-16 Grifols Grupo Sa Utilizacion del acido tranexamico para la preparacion de una composicion de fibrinogeno humano.
DK1202754T3 (da) * 1999-08-13 2004-03-08 Omrix Biopharm Sa Anvendelse af fibrinogene multimerer i fibrinklæbere
US6916911B1 (en) 1999-08-13 2005-07-12 Omrix Biopharmaceuticals Sa Use of fibrinogen multimers
RU2158130C1 (ru) * 1999-12-17 2000-10-27 Нижегородское государственное предприятие по производству бактерийных препаратов фирма "ИмБио" Способ получения фибриногена
JP4660048B2 (ja) * 1999-12-23 2011-03-30 シーエスエル、リミテッド 血漿プロテアーゼからのフィブリノゲンの分離
US6468660B2 (en) 2000-12-29 2002-10-22 St. Jude Medical, Inc. Biocompatible adhesives
US20020146409A1 (en) * 2001-01-30 2002-10-10 Herring Steven W. Methods for stabilizing lyophilized blood proteins
US20020173770A1 (en) * 2001-05-16 2002-11-21 Flory Alan R. Adhesive delivery system
US20030224994A1 (en) * 2002-04-05 2003-12-04 Newton Colin John Storage stable liquid sealer protein complex
US7992725B2 (en) 2002-05-03 2011-08-09 Biomet Biologics, Llc Buoy suspension fractionation system
US7832566B2 (en) * 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US7374678B2 (en) * 2002-05-24 2008-05-20 Biomet Biologics, Inc. Apparatus and method for separating and concentrating fluids containing multiple components
US20030205538A1 (en) * 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
AU2003249642A1 (en) * 2002-05-24 2003-12-12 Biomet Manufacturing Corp. Apparatus and method for separating and concentrating fluids containing multiple components
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
FR2857267B1 (fr) * 2003-07-09 2006-03-10 Lab Francais Du Fractionnement Formulation stabilisante et solubilisante pour les proteines cryoprecipitables.
EP1763552A1 (fr) * 2004-07-08 2007-03-21 Symatese Colle lyophilisee a base de collagene et son utilisation pour la fabrication de protheses collantes
FR2872821B1 (fr) * 2004-07-08 2006-09-29 Symatese Soc Par Actions Simpl Colle lyophilisee a base de collagene et son utilisation pour la fabrication de protheses collantes
US7866485B2 (en) 2005-02-07 2011-01-11 Hanuman, Llc Apparatus and method for preparing platelet rich plasma and concentrates thereof
EP2666493B1 (en) * 2005-02-07 2020-09-23 Hanuman LLC Platelet rich plasma concentrate apparatus
US7708152B2 (en) * 2005-02-07 2010-05-04 Hanuman Llc Method and apparatus for preparing platelet rich plasma and concentrates thereof
US20070248653A1 (en) * 2006-04-20 2007-10-25 Cochrum Kent C Hemostatic compositions and methods for controlling bleeding
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8430813B2 (en) * 2006-05-26 2013-04-30 Depuy Spine, Inc. Illuminated surgical access system including a surgical access device and integrated light emitter
JP5393447B2 (ja) * 2007-03-22 2014-01-22 一般財団法人化学及血清療法研究所 固体状フィブリノゲン製剤
EP2146794B1 (en) * 2007-04-12 2016-10-19 Biomet Biologics, LLC Buoy suspension fractionation system
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
WO2009108890A1 (en) 2008-02-27 2009-09-03 Biomet Biologics, Llc Methods and compositions for delivering interleukin-1 receptor antagonist
EP2254991B1 (en) * 2008-02-29 2018-08-22 Biomet Manufacturing, LLC A system and process for separating a material
US8012077B2 (en) * 2008-05-23 2011-09-06 Biomet Biologics, Llc Blood separating device
US8187475B2 (en) 2009-03-06 2012-05-29 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US9011800B2 (en) * 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
KR102109317B1 (ko) 2011-12-29 2020-05-29 옴릭스 바이오파머슈티컬스 리미티드 고체 단백질 조성물의 신속한 용해를 위한 방법 및 장치
ES2642383T3 (es) 2012-03-13 2017-11-16 Octapharma Ag Procedimiento mejorado de producción de fibrinógeno y fibrinógeno producido por el mismo
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
EP3769618A1 (en) 2014-06-09 2021-01-27 Terumo BCT, Inc. Lyophilization container
US9713810B2 (en) 2015-03-30 2017-07-25 Biomet Biologics, Llc Cell washing plunger using centrifugal force
US9757721B2 (en) 2015-05-11 2017-09-12 Biomet Biologics, Llc Cell washing plunger using centrifugal force
US20170136070A1 (en) * 2015-11-18 2017-05-18 Dregalla Patent Holdco, LLC Acellular Regenerative Products and Methods of Their Manufacture
CN111295094A (zh) 2017-10-09 2020-06-16 泰尔茂比司特生物技术有限公司 冻干容器及使用冻干容器的方法
US11604026B2 (en) 2019-03-14 2023-03-14 Terumo Bct Biotechnologies, Llc Lyophilization loading tray assembly and system
US20240342253A1 (en) 2021-08-13 2024-10-17 Biotest Ag Fibrinogen compositions and methods of preparation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2461969A1 (de) * 1974-12-31 1976-07-08 Behringwerke Ag Stabiles blutplasma, verfahren zu dessen herstellung und seine verwendung als vergleichsplasma bei gerinnungs- untersuchungen
JPS5598196A (en) * 1979-01-16 1980-07-25 Meito Sangyo Kk Fractionation of fibrinogen or its constituents and their use
AT359653B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
AT359652B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
US4362661A (en) * 1979-08-09 1982-12-07 Teijin Limited Immunoglobulin composition having a high monomer content, and process for production thereof
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
US4294753A (en) * 1980-08-04 1981-10-13 The Regents Of The University Of California Bone morphogenetic protein process

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5318782A (en) * 1986-10-03 1994-06-07 Weis Fogh Ulla S Method for preparing tissue repair promoting substances

Also Published As

Publication number Publication date
DK44483A (da) 1983-08-05
NO155177B (no) 1986-11-17
ES519469A0 (es) 1984-03-16
IL67823A (en) 1986-01-31
EP0085923A1 (de) 1983-08-17
AR231233A1 (es) 1984-10-31
IE830207L (en) 1983-08-04
EP0085923B1 (de) 1986-10-15
DK44483D0 (da) 1983-02-03
IL67823A0 (en) 1983-06-15
GR77184B (cg-RX-API-DMAC7.html) 1984-09-11
FI77985C (fi) 1989-06-12
US4650678A (en) 1987-03-17
AU1110583A (en) 1983-08-11
AU556068B2 (en) 1986-10-23
DK158282B (da) 1990-04-30
JPH047328B2 (cg-RX-API-DMAC7.html) 1992-02-10
PT76193A (de) 1983-03-01
ATE22806T1 (de) 1986-11-15
NZ203164A (en) 1985-08-30
EP0085923B2 (de) 1991-01-23
FI830361L (fi) 1983-08-05
ZA83726B (en) 1983-10-26
FI830361A0 (fi) 1983-02-02
JPS58135817A (ja) 1983-08-12
ES8403321A1 (es) 1984-03-16
FI77985B (fi) 1989-02-28
DE3366841D1 (en) 1986-11-20
PT76193B (de) 1986-01-10
NO830371L (no) 1983-08-05
CA1186995A (en) 1985-05-14
DK158282C (da) 1990-10-01
IE54547B1 (en) 1989-11-08

Similar Documents

Publication Publication Date Title
DE3203775A1 (de) Fibrinogenzubereitung, verfahen zu ihrer herstellungund ihre verwendung
DE60027695T2 (de) Verfahren zur herstellung von fibrinogen und fibronectin sowie proteinzusammesetzungen, welche damit herstellbar sind
EP0253198B2 (de) Einkomponenten-Gewebekleber sowie Verfahren zu seiner Herstellung
AT397203B (de) Gewebeklebstoff
DE4202667C1 (cg-RX-API-DMAC7.html)
EP0103196B2 (de) Pasteurisiertes Human-Fibrinogen (HF), Verfahren zu dessen Herstellung und dessen Verwendung
EP1131110A1 (de) Stabilisierte proteinzubereitungen für einen gewebekleber
EP0018561A2 (de) Verfahren zur Stabilisierung von Blutgerinnungsfaktoren
EP1393741A1 (de) Lagerungsstabile, flüssige Fibrinogen-Formulierung
DE4001451A1 (de) Stabile injizierbare loesungen von faktor viii und faktor ix
EP0784632A1 (de) Verfahren zur gewinnung von hochreinem von willebrand-faktor
EP0855917A1 (de) Stabile pharmazeutische darreichungsformen enthaltend parathormon
EP2293776B1 (de) Lagerstabiles, funktionell intaktes virus-inaktiviertes fibrinogen
EP0018353A1 (de) Verfahren zur Herstellung von nebenwirkungsfreien Plasmafraktionen
EP0458950B1 (de) K2p pro-stabilisierung
EP1405863A1 (de) Konzentrat eines Faktor VIII:C-haltigen von-Willebrand-Faktors und das dazu gehörige Verfahren
DE69425581T2 (de) Methode zur stabilisierung von protein c oder aktiviertem protein c und stabilisierte verbindungen
EP0853944B1 (de) Präparation umfassend Thiolgruppen-haltige Proteine
DE2500810A1 (de) Reinigen von plasminogen
DE69023470T2 (de) Pasteurisierensverfahren und pasteurisierter kleber zum binden von menschlichen oder tierischen geweben.
DE102004037805B3 (de) Verfahren zur Hitzebehandlung fibrinogenhaltiger pharmazeutischer Zubereitungen
CH498089A (de) Verfahren zum Herstellen von neuen SH- oder SS-Glutathionsalzen

Legal Events

Date Code Title Description
8130 Withdrawal